5. CLINICAL PRESENTATION
Symptoms are primarily neurological.
Early symptoms can include nausea,
headache, and vomiting.
In chronic hyponatremia, patients suffer from
vomiting, nausea, confusion and seizures,
usually at plasma Na+ concentration <125
mM.
Even patients who are judged
“asymptomatic” can manifest subtle gait and
cognitive defects that reverse with correction
of hyponatremia; chronic “asymptomatic”
hyponatremia increases the risk of falls and
increases the risk of bony fractures.
6. DIAGNOSTIC EVALUATION
DETAILED DRUG HISTORY
VOLUME STATUS
RADIOLOGIC IMAGING TO RULE
OUT CNS OR PULMONARY
CAUSES
LAB INVESTIGATIONS
7. LAB INVESTIGATIONS
SERUM OSMOLALTIY
BUN and CREATININE
HYPERKALEMIA
SERUM GLUCOSE
URIC ACID
THYROID/ADRENAL/PITUITARY
FUNCTION
URINE ELECTROLYTES AND
OSMOLALTIY
8. TREATMENT GOALS
PRESENCE AND SEVERITY OF
SYMPTOMS DETERMINE THE
URGENCY AND GOALS OF THERAPY
CHRONIC HYPONATREMIA ARE
MORE PRONE TO ODS IF NA IS
CORRECTED >8-10mM IN 24HRS OR
>18mM IN 48HRS
RESPONSE TO SALINE OR AVP
ANTAGONISTS CAN BE HIGHLY
UNPREDICTABLE
9. Na DEFICIT= TBW*(DESIRED-ACTUAL)
TBW=
0.6(MALES)/0.5(FEMALES)*WEIGHT
1000ml of 3% NS = 514 mEq of Na
2 ml of 3% NS = 1mEq of Na
6.5ml of NS = 1mEq of Na
10. ACUTE
• THE RISE SHOULD BE 4-6mM
• USE OF SUPPLEMENTAL O2 AND
VENTILATORY SUPPORT
• IV LOOP DIURETICS IN
PULMONARY EDEMA
• VAPTANS HAVE NO ROLE
11. CHRONIC
• RATE OF CORRECTION- <10-
12mM IN 24HRS OR <18mM IN
48HRS
• VAPTANS EFFECTIVE IN
HYPERVOLEMIC CONDITIONS
• VAPTANS CAN CAUSE LIVER
INJURY AND SHOULDN’T BE USED
MORE THAN 1-2MONTHS WITH
CLOSE MONITORING
14. CAUSES
• Elderly
• primary or metastatic tumor, occlusion or
ligation of the anterior communicating
artery, trauma, hydrocephalus, and
inflammation.
• Insensible losses of water-fever, exercise,
heat exposure, severe burns, or
mechanical ventilation
• Diarrhea – osmotic diarrhea
• Osmotic diuresis-hyperglycemia, excess
urea, postobstructive diuresis, or mannitol
15. CLINICAL FEATURES
Altered mental status
Mild confusion
Lethargy
Deep coma
Parenchymal or subarachnoid
hemorrhages and/or subdural
hematomas;